StockSelector.com
  Research, Select, & Monitor Sunday, August 25, 2019 4:54:26 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Nabriva Therapeutics AG$1.98($.09)(4.35%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Nabriva Therapeutics AG has an overall rank of 6678 out of 7130 stocks based on 5 positive rankings and 7 negative rankings.

Positive Rankings
Low vPut/Call
Nabriva Therapeutics AG has a low Put/Call ratio of 0.04 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Nabriva Therapeutics AG is ranked 59.
Low Put/Call
Nabriva Therapeutics AG has a low Put/Call ratio of 0.04 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Nabriva Therapeutics AG is ranked 106.
Estimated Revenue Growth
Nabriva Therapeutics AG rank is 107
Debt-to-Equity
Nabriva Therapeutics AG rank is 1295
Up EPS Surprise
Nabriva Therapeutics AG beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative Net Margin
Nabriva Therapeutics AG rank is 119
Price-to-Sales
Nabriva Therapeutics AG rank is 171
Price-to-Book
Nabriva Therapeutics AG rank is 186
Negative ROE
Nabriva Therapeutics AG rank is 216
10 Day Loss
Nabriva Therapeutics AG rank is 256
Negative ROA
Nabriva Therapeutics AG rank is 258
90 Day Loss
Nabriva Therapeutics AG rank is 1103







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.